 |
biocarbonate infusate |
|---|---|
| Trade Name | Normocarb Hf |
| Orphan Indication | Use in the management of patients undergoing continuous renal replacement therapy with hemofiltration |
| USA Market Approval | USA |
| USA Designation Date | 2005-08-09 00:00:00 |
| Sponsor | Dialysis Solutions, Inc.;14 Emmett Place, Whitby, Ontario L1R 2B4; |
